Showing results (61-70 of 139) with videos related to
Sort By:
Pageof 14
Postgraduate Medical Journal|April 21, 2019
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapyJoanne W Chiu, Roland Leung, Vikki Tang, et al.Journal of the National Cancer Institute|March 15, 2022
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular CarcinomaHiroto Kikuchi, Aya Matsui, Satoru Morita, et al.Cancers|April 30, 2021
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCCYawen Dong, Jeffrey Sum Lung Wong, Ryohichi Sugimura, et al.Journal of Oncology|May 8, 2014
Androgen deprivation therapy and cardiovascular risk in chinese patients with nonmetastatic carcinoma of prostateGang Huang, Chun-Yip Yeung, Ka Kui Lee, et al.Liver Cancer|June 24, 2026
Etiology-Based Treatment for Unresectable/Advanced Hepatocellular Carcinoma: Focus on Viral Hepatitis and Metabolic Dysfunction-Associated SteatohepatitisFrances Sze Kei Sun, Jeffrey Sum Lung Wong, Lung-Yi Mak, et al.Liver Cancer|March 6, 2023
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-AnalysisKhi Yung Fong, Joseph Jonathan Zhao, Rehena Sultana, et al.The Oncologist|December 3, 2011
The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC)Hilda Wong, Yuen Fong Tang, Tzy-Jyun Yao, et al.The Oncologist|October 3, 2022
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2Richard S Finn, Thomas Yau, Chih-Hung Hsu, et al.Cancer|April 21, 2012
The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefitsJoanne Chiu, Yuen Fong Tang, Tzy-Jyun Yao, et al.Translational Gastroenterology and Hepatology|February 1, 2017
Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?Vincent S K Yip, Tan To Cheung, Ronnie T P Poon, et al.Pageof 14